Report Detail

Pharma & Healthcare Global (United States, European Union and China) Intravenous (IV) Solutions Market Research Report 2019-2025

  • RnM3609011
  • |
  • 22 July, 2019
  • |
  • Global
  • |
  • 110 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Intravenous (IV) solutions are fluids which are intended to be administered to a patient directly into the venous circulation.
Key factors driving market expansion include the rapidly increasing natality rate including a high percentage of premature births and malnutrition.
In 2019, the market size of Intravenous (IV) Solutions is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intravenous (IV) Solutions.

This report studies the global market size of Intravenous (IV) Solutions, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Intravenous (IV) Solutions sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
ICU Medical Inc. (U.S.)
B. Braun Melsungen AG (Germany)
Fresenius Kabi AG (Germany)
Baxter (U.S.)
Amanta Healthcare (India)
Terumo Medical Corporation (Tokyo)
Grifols S.A. (Spain)
...

Market Segment by Product Type
Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Market Segment by Application
Hospital & Clinics
Ambulatory
Home Care

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Intravenous (IV) Solutions status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Intravenous (IV) Solutions manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Intravenous (IV) Solutions are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Intravenous (IV) Solutions Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Peripheral Parenteral Nutrition
      • 1.3.3 Total Parenteral Nutrition
    • 1.4 Market Segment by Application
      • 1.4.1 Global Intravenous (IV) Solutions Market Share by Application (2019-2025)
      • 1.4.2 Hospital & Clinics
      • 1.4.3 Ambulatory
      • 1.4.4 Home Care
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Intravenous (IV) Solutions Market Size
      • 2.1.1 Global Intravenous (IV) Solutions Revenue 2014-2025
      • 2.1.2 Global Intravenous (IV) Solutions Sales 2014-2025
    • 2.2 Intravenous (IV) Solutions Growth Rate by Regions
      • 2.2.1 Global Intravenous (IV) Solutions Sales by Regions 2014-2019
      • 2.2.2 Global Intravenous (IV) Solutions Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Intravenous (IV) Solutions Sales by Manufacturers
      • 3.1.1 Intravenous (IV) Solutions Sales by Manufacturers 2014-2019
      • 3.1.2 Intravenous (IV) Solutions Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Intravenous (IV) Solutions Revenue by Manufacturers (2014-2019)
      • 3.2.2 Intravenous (IV) Solutions Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Intravenous (IV) Solutions Market Concentration Ratio (CR5 and HHI)
    • 3.3 Intravenous (IV) Solutions Price by Manufacturers
    • 3.4 Key Manufacturers Intravenous (IV) Solutions Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Intravenous (IV) Solutions Market
    • 3.6 Key Manufacturers Intravenous (IV) Solutions Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Peripheral Parenteral Nutrition Sales and Revenue (2014-2019)
      • 4.1.2 Total Parenteral Nutrition Sales and Revenue (2014-2019)
    • 4.2 Global Intravenous (IV) Solutions Sales Market Share by Type
    • 4.3 Global Intravenous (IV) Solutions Revenue Market Share by Type
    • 4.4 Intravenous (IV) Solutions Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Intravenous (IV) Solutions Sales by Application

    6 United States

    • 6.1 United States Intravenous (IV) Solutions Breakdown Data by Company
    • 6.2 United States Intravenous (IV) Solutions Breakdown Data by Type
    • 6.3 United States Intravenous (IV) Solutions Breakdown Data by Application

    7 European Union

    • 7.1 European Union Intravenous (IV) Solutions Breakdown Data by Company
    • 7.2 European Union Intravenous (IV) Solutions Breakdown Data by Type
    • 7.3 European Union Intravenous (IV) Solutions Breakdown Data by Application

    8 China

    • 8.1 China Intravenous (IV) Solutions Breakdown Data by Company
    • 8.2 China Intravenous (IV) Solutions Breakdown Data by Type
    • 8.3 China Intravenous (IV) Solutions Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Intravenous (IV) Solutions Breakdown Data by Company
    • 9.2 Rest of World Intravenous (IV) Solutions Breakdown Data by Type
    • 9.3 Rest of World Intravenous (IV) Solutions Breakdown Data by Application
    • 9.4 Rest of World Intravenous (IV) Solutions Breakdown Data by Countries
      • 9.4.1 Rest of World Intravenous (IV) Solutions Sales by Countries
      • 9.4.2 Rest of World Intravenous (IV) Solutions Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 ICU Medical Inc. (U.S.)
      • 10.1.1 ICU Medical Inc. (U.S.) Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.1.4 Intravenous (IV) Solutions Product Introduction
      • 10.1.5 ICU Medical Inc. (U.S.) Recent Development
    • 10.2 B. Braun Melsungen AG (Germany)
      • 10.2.1 B. Braun Melsungen AG (Germany) Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.2.4 Intravenous (IV) Solutions Product Introduction
      • 10.2.5 B. Braun Melsungen AG (Germany) Recent Development
    • 10.3 Fresenius Kabi AG (Germany)
      • 10.3.1 Fresenius Kabi AG (Germany) Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.3.4 Intravenous (IV) Solutions Product Introduction
      • 10.3.5 Fresenius Kabi AG (Germany) Recent Development
    • 10.4 Baxter (U.S.)
      • 10.4.1 Baxter (U.S.) Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.4.4 Intravenous (IV) Solutions Product Introduction
      • 10.4.5 Baxter (U.S.) Recent Development
    • 10.5 Amanta Healthcare (India)
      • 10.5.1 Amanta Healthcare (India) Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.5.4 Intravenous (IV) Solutions Product Introduction
      • 10.5.5 Amanta Healthcare (India) Recent Development
    • 10.6 Terumo Medical Corporation (Tokyo)
      • 10.6.1 Terumo Medical Corporation (Tokyo) Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.6.4 Intravenous (IV) Solutions Product Introduction
      • 10.6.5 Terumo Medical Corporation (Tokyo) Recent Development
    • 10.7 Grifols S.A. (Spain)
      • 10.7.1 Grifols S.A. (Spain) Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Intravenous (IV) Solutions
      • 10.7.4 Intravenous (IV) Solutions Product Introduction
      • 10.7.5 Grifols S.A. (Spain) Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Intravenous (IV) Solutions Sales Channels
      • 11.2.2 Intravenous (IV) Solutions Distributors
    • 11.3 Intravenous (IV) Solutions Customers

    12 Market Forecast

    • 12.1 Global Intravenous (IV) Solutions Sales and Revenue Forecast 2019-2025
    • 12.2 Global Intravenous (IV) Solutions Sales Forecast by Type
    • 12.3 Global Intravenous (IV) Solutions Sales Forecast by Application
    • 12.4 Intravenous (IV) Solutions Forecast by Regions
      • 12.4.1 Global Intravenous (IV) Solutions Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Intravenous (IV) Solutions Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Intravenous (IV) Solutions. Industry analysis & Market Report on Intravenous (IV) Solutions is a syndicated market report, published as Global (United States, European Union and China) Intravenous (IV) Solutions Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Intravenous (IV) Solutions market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,610.88
      3,916.32
      5,221.76
      3,047.12
      4,570.68
      6,094.24
      504,923.20
      757,384.80
      1,009,846.40
      273,912.80
      410,869.20
      547,825.60
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report